Shilpa Medicare informs about outcome of board meeting

29 Oct 2021 Evaluate

Shilpa Medicare has informed that the Board of Directors of Shilpa Medicare at their meeting held today i.e., 29 October 2021 resolved the following: Approval of Unaudited Standalone and Consolidated Financial Results of the Company for the Second Quarter and Half Year ended 30 September 2021. The Copy of Financial Results and Limited Review Report is enclosed. The Board meeting commenced at 12:30 PM and concluded at 03: 00 PM.

The above information is a part of company’s filings submitted to BSE.

Shilpa Medicare Share Price

300.20 13.00 (4.53%)
03-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1702.80
Dr. Reddys Lab 1235.00
Cipla 1322.45
Zydus Lifesciences 902.95
Lupin 2186.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×